Author

A. G. Thomas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:C. elegans· 1 Organism:virus· 1

Frequent Co-Authors

A. K. Jayabalan· 1 shared A. Leung· 1 shared B. Murphy· 1 shared B. S. Slusher· 1 shared C. M. Donnelly· 1 shared J. A. Goodman· 1 shared J. A. Joseph· 1 shared J. Ahmed· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. K. Jayabalan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A 2D Fragment-Assisted Protein Mimetic Approach to Rescue α-Synuclein Aggregation Mediated Early and Post-Disease Parkinsons Phenotypes

S. Kumar, N. H. Stillman, J. A. Joseph, J. Ahmed, R. A. Dohoney, T. D. Ball, A. G. Thomas, T. C. Fitch, C. M. Donnelly

This paper develops a 2D-FAST method to identify antagonists of α-synuclein aggregation, showing efficacy in C. elegans models of Parkinson's disease.

bioRxiv · Jul 11, 2022 · PreprintBiochemistry

High-throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain

M. A. Dasovich, J. Zhuo, A. G. Thomas, J. A. Goodman, R. L. McPherson, A. K. Jayabalan, V. F. Busa, S.-J. Cheng, B. Murphy, K. R. Redinger, T. Tsukamoto, B. S. Slusher, J. Bosch, J. Wei, A. Leung

The paper develops a high-throughput assay for screening inhibitors of the SARS-CoV-2 Mac1 macrodomain and identifies dasatinib and dihydralazine as inhibitors with selectivity over human MacroD2.

bioRxiv · Oct 7, 2021Biochemistry